Ophthalmology Times Newsletter

To view this email as a web page, click here.

Examining comparable surgical methods for IOL dislocation

A complication of implantation of an intraocular lens (IOL) in the capsular bag is its dislocation, which can happen years after an uncomplicated cataract surgery. The average time between IOL implantation and dislocation is 7 to 10 years. The notable culprits that are involved in IOL dislocation are pseudoexfoliation, high myopia, and previous vitrectomy.

Read on

Intraoperative surgical methods key to AMD treatment

Targeted subretinal surgery for delivery of a novel biosynthetic retinal pigment epithelial (RPE) monolayer in eyes with advanced dry age-related macular degeneration (AMD) has been shown to be feasible using new intraoperative surgical methods, according to Amir H. Kashani, MD, PhD.

Find out more

Treating dry eye with recombinant human nerve growth factor

Moderate-to-severe dry eye disease is coming under attack from a new direction. Oxervate (Dompé), a first-in-class recombinant human nerve growth factor (rhNGF) that successfully treats neurotrophic keratitis, is being investigated in a phase IIb trial to see how patients with moderate-to-severe dry eye disease fare with this therapy.

Learn more

Putting Cataracts into Perspective

Elevate the premium cataract experience in your practice with InSight Magazine, a resource to help patients understand their options for a full range of vision.

Download the magazine today.

Gene therapy for LHON: Deciphering phase III data

Budding technology could be an OCT analysis game-changer

Weigh risk, benefits of cataract surgery for your patients

Teleglaucoma lets patients be more engaged in care

Safety key for intracamerally injected mydriatic agents in cataract surgery

Understand the expanding role of IPL in dry eye disease

These 3 things are part of a cataract surgeon’s signature

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.